[Management Team] [Board of Directors] [Corporate Info] [Scientific Advisory Board]

 

• Peter Elias, M.D., Professor of Dermatology at the University of
  California, San Francisco and Ceragenix's Chief Scientific Officer
   
• Henry F. Chambers, M.D., Professor of Medicine, University of
  California, San Francisco and Chief, Division of Infectious Diseases,
  San Francisco General Hospital
   
• Tomas Ganz, Ph.D., M.D., Professor of Medicine and Pathology, and
  Director, Will Rogers Pulmonary Research Laboratory, David Geffen School
  of Medicine, University of California, Los Angeles
   
• Richard Gallo, M.D., Professor of Medicine and Pediatrics, and Chief
  of Division of Dermatology, University of California, School of Medicine
   
• Sean P. Gorman, Ph.D., Head of School and Chair in Pharmaceutical
  Microbiology, Queen's University, Belfast, UK
   
• Donald Y. M. Leung, Ph.D., M.D.Professor and Head of Pediatric
  Allergy-Immunology at The National Jewish Medical and Research Center in
  Denver, Colorado.
  
  
• Michael J. Rybak, PharmD, MPH, FCCP, FIDSA, Associate Dean for Research and Professor of Pharmacy at the Eugene Applebaum College of Pharmacy and Health Sciences (EACPHS), and an Adjunct Professor of medicine in the Division of Infectious Diseases at the School of Medicine at Wayne State University in Detroit, Michigan
  
  
• Michael S. Niederman MD, FACP, FCCP, FCCM, Professor of Medicine and Vice-Chairman of the Department of Medicine at the State University of New York at Stony Brook and he is also Chairman of the Department of Medicine at Winthrop-University Hospital in Mineola, New York